Vasopressin (AVP) acts in the area postrema (AP) to augment baroreflex opposition of the exercise pressor reflex

Charles L Stebbins, S. Bonigut, P. A. Munch

Research output: Contribution to journalArticle

Abstract

Circulating AVP can enhance baroreflex function via its action in the AP. In addition, the exercise pressor reflex is enhanced by intravenous injection of an AVP V, receptor antagonist or chemical inhibition of cell bodies in the AP. We tested the hypothesis that AVP acts in the AP during static contraction to enhance baroreflex function. Thus, blood pressure (MAP) and heart rate (HR) responses to 30 s of electrically stimulated hindlimb contraction were compared before and after bilateral microinjections of 200 nl of the selective AVP V, receptor antagonist d(CH 2) 5 Tyr(Me)-AVP (1 ng/nl) into the AP of the anesthetized cat (α-chloralose; n=4). This protocol was repeated in 3 other cats where sinoaortic denervation was performed prior to any intervention. Microinjection of the V, receptor antagonist into the AP augmented the MAP and HR responses to static contraction from 47±8 to 69±12 mmHg and from 14±3 to 20±5 beats/min, respectively In the SAD cats, injection of the V, antagonist had no effect on MAP or HR. Intravenous injection of a similar dose of the antagonist (n=2) also had no effect on contraction-induced increases in MAP or HR. These results suggest that baroreflex function is enhanced during static contraction due to the action of AVP in the AP.

Original languageEnglish (US)
JournalFASEB Journal
Volume11
Issue number3
StatePublished - 1997

Fingerprint

Area Postrema
vasopressin
Baroreflex
reflexes
Vasopressins
Reflex
antagonists
exercise
heart rate
Heart Rate
cats
Cats
intravenous injection
receptors
Microinjections
Intravenous Injections
chloralose
Chloralose
Blood pressure
blood pressure

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

Vasopressin (AVP) acts in the area postrema (AP) to augment baroreflex opposition of the exercise pressor reflex. / Stebbins, Charles L; Bonigut, S.; Munch, P. A.

In: FASEB Journal, Vol. 11, No. 3, 1997.

Research output: Contribution to journalArticle

@article{d9d285dd26eb4916b719b97da062f937,
title = "Vasopressin (AVP) acts in the area postrema (AP) to augment baroreflex opposition of the exercise pressor reflex",
abstract = "Circulating AVP can enhance baroreflex function via its action in the AP. In addition, the exercise pressor reflex is enhanced by intravenous injection of an AVP V, receptor antagonist or chemical inhibition of cell bodies in the AP. We tested the hypothesis that AVP acts in the AP during static contraction to enhance baroreflex function. Thus, blood pressure (MAP) and heart rate (HR) responses to 30 s of electrically stimulated hindlimb contraction were compared before and after bilateral microinjections of 200 nl of the selective AVP V, receptor antagonist d(CH 2) 5 Tyr(Me)-AVP (1 ng/nl) into the AP of the anesthetized cat (α-chloralose; n=4). This protocol was repeated in 3 other cats where sinoaortic denervation was performed prior to any intervention. Microinjection of the V, receptor antagonist into the AP augmented the MAP and HR responses to static contraction from 47±8 to 69±12 mmHg and from 14±3 to 20±5 beats/min, respectively In the SAD cats, injection of the V, antagonist had no effect on MAP or HR. Intravenous injection of a similar dose of the antagonist (n=2) also had no effect on contraction-induced increases in MAP or HR. These results suggest that baroreflex function is enhanced during static contraction due to the action of AVP in the AP.",
author = "Stebbins, {Charles L} and S. Bonigut and Munch, {P. A.}",
year = "1997",
language = "English (US)",
volume = "11",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "3",

}

TY - JOUR

T1 - Vasopressin (AVP) acts in the area postrema (AP) to augment baroreflex opposition of the exercise pressor reflex

AU - Stebbins, Charles L

AU - Bonigut, S.

AU - Munch, P. A.

PY - 1997

Y1 - 1997

N2 - Circulating AVP can enhance baroreflex function via its action in the AP. In addition, the exercise pressor reflex is enhanced by intravenous injection of an AVP V, receptor antagonist or chemical inhibition of cell bodies in the AP. We tested the hypothesis that AVP acts in the AP during static contraction to enhance baroreflex function. Thus, blood pressure (MAP) and heart rate (HR) responses to 30 s of electrically stimulated hindlimb contraction were compared before and after bilateral microinjections of 200 nl of the selective AVP V, receptor antagonist d(CH 2) 5 Tyr(Me)-AVP (1 ng/nl) into the AP of the anesthetized cat (α-chloralose; n=4). This protocol was repeated in 3 other cats where sinoaortic denervation was performed prior to any intervention. Microinjection of the V, receptor antagonist into the AP augmented the MAP and HR responses to static contraction from 47±8 to 69±12 mmHg and from 14±3 to 20±5 beats/min, respectively In the SAD cats, injection of the V, antagonist had no effect on MAP or HR. Intravenous injection of a similar dose of the antagonist (n=2) also had no effect on contraction-induced increases in MAP or HR. These results suggest that baroreflex function is enhanced during static contraction due to the action of AVP in the AP.

AB - Circulating AVP can enhance baroreflex function via its action in the AP. In addition, the exercise pressor reflex is enhanced by intravenous injection of an AVP V, receptor antagonist or chemical inhibition of cell bodies in the AP. We tested the hypothesis that AVP acts in the AP during static contraction to enhance baroreflex function. Thus, blood pressure (MAP) and heart rate (HR) responses to 30 s of electrically stimulated hindlimb contraction were compared before and after bilateral microinjections of 200 nl of the selective AVP V, receptor antagonist d(CH 2) 5 Tyr(Me)-AVP (1 ng/nl) into the AP of the anesthetized cat (α-chloralose; n=4). This protocol was repeated in 3 other cats where sinoaortic denervation was performed prior to any intervention. Microinjection of the V, receptor antagonist into the AP augmented the MAP and HR responses to static contraction from 47±8 to 69±12 mmHg and from 14±3 to 20±5 beats/min, respectively In the SAD cats, injection of the V, antagonist had no effect on MAP or HR. Intravenous injection of a similar dose of the antagonist (n=2) also had no effect on contraction-induced increases in MAP or HR. These results suggest that baroreflex function is enhanced during static contraction due to the action of AVP in the AP.

UR - http://www.scopus.com/inward/record.url?scp=33750126152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750126152&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33750126152

VL - 11

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 3

ER -